Log in or Sign up for Free to view tailored content for your specialty!
Headache News
Atogepant linked to rapid reduction of migraine symptoms
In three clinical trials, treatment with atogepant relieved migraine symptoms as soon as day 1, with consistent reductions through 4 weeks compared with placebo, according to research published in Neurology.
Top neurology stories of 2024: The end of Aduhelm, misconduct in the NIH and more
Healio Neurology looks back at the most-viewed stories during the past year. Highlights include Biogen’s discontinuation of Aduhelm and a former NIH neuroscience director found guilty of research misconduct.
Migraine management: A guide for providers to optimize preventive and acute treatments
Headache is one of the most common complaints seen by health care providers. There are various types of primary headache disorders, with the most common being migraine, tension headache and cluster headache.
Log in or Sign up for Free to view tailored content for your specialty!
Neurologic symptoms of long COVID more common in younger adults
Younger and middle-aged adults were more often affected by neurologic symptoms of long COVID than their older counterparts, regardless of how severe their initial infection was, data in Annals of Neurology show.
A potential new paradigm for treating acute migraine: Timolol nasal spray
Affecting more than 1 billion people worldwide, migraine is among the most common neurological diseases. During their lives, 43% of women and 18% of men develop migraine.
Study: Pediatric migraine drugs more effective with vitamin supplements
Pregabalin and topiramate significantly reduced the frequency and intensity of migraines in children and adolescents, especially when combined with vitamin supplements, according to a meta-analysis published in JAMA Network Open.
Managing migraine pain before it begins: Understanding prodrome, early treatment options
Migraine is a complex neurological disease that disproportionately affects women during their most productive years.
Headache management in kids: ‘When to worry and what to do’
ORLANDO, Fla. — Although children often suffer from headache, there are few controlled trials that include this unique patient population, leaving clinicians to rely on their experience rather than data, according to a presenter.
One in three former professional football players believe they have CTE
Around one-third of former professional football players perceived themselves as having chronic traumatic encephalopathy, according to results from a cross-sectional study published in JAMA Neurology.
Focus on access, health literacy to improve headache management in rural areas
ORLANDO, Fla. — To properly address headache care gaps in rural areas, clinicians must focus on boosting access, improving health literacy and formulating simple but informative plans for medication usage, according to a speaker.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read